Development and pharmacokinetics of nimodipine-loaded liposomes

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 9, 2006, Pages 1289-1294

  Wang, Zhixuan ^a,c   Deng, Yingjie ^a   Zhang, Xiaopeng ^a   Wang, Ting ^a   Wu, Fenglan ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOMAL NIMODIPINE; LIPOSOME; NIMODIPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; MALE; MOUSE; NONHUMAN; OSMOSIS; PARTICLE SIZE;

ANIMALS; AREA UNDER CURVE; BLOOD-BRAIN BARRIER; BRAIN; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; HALF-LIFE; INJECTIONS, INTRAVENOUS; LIPOSOMES; MALE; METABOLIC CLEARANCE RATE; MICE; NIMODIPINE; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; SOLUBILITY; SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 33748299197     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.9.0017     Document Type: Article

References (9)

1. Ban, T. A., Morey, L., Aguglia, E., Azzarelli, O., Balsano, F., Marigliano, V., Caglieris, N., Sterlicchio, M., Capurso, A., Tomasi, N. A. (1990) Nimodipine in the treatment of old age dementias. Prog. Neuropsychopharmacol. Biol. Psychiatry 14: 525-551
2. Blardi, P., Urso, R., De Lalla, A., Volpi, L., Perri, T. D., Auteri, A. (2002) Nimodipine: drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia. Clin. Pharmacol. Ther. 72: 556-561
3. Charrois, G. J., Allen, T. M. (2003) Rate of biodistribution of stealth liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity. Biochim. Biophys. Acta. 1609: 102-108
4. Chinese Pharmacopoeia (2005) Chinese Pharmacopoeia. Chinese Pharmacopoeia Committee, Chemical Industrial Press, Beijing
5. Langley, M. S., Sorkin, E. M. (1989) Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 37: 669-699
6. Mourao, S. C., Costa, P. I., Salgado, H. R., Gremiao, M. P. (2005) Improvement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomes. Int. J. Pharm. 295: 157-162
7. Xia, M. S., Huang, L. Y., Yin, L. L. (2002) Study on the preparation and pharmacokinetics of nimodipine proliposomes. West China J. Pharm. Sci. 17: 98-103
8. Yang, D., Zhu, J., Zheng, Y., Ge, L. (2006) Preparation, characterization, and pharmacokinetics of sterically stabilized nimodipine-containing liposomes. Drug Dev. Ind. Pharm. 32: 219-227
9. Zhang, H. (1998) Compatibility of nimodipine. J. Chin. Pharm. 33: 415-417